IM5

2-amino-7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one

Created:	2010-11-05
Last modified:	2020-06-05

Find Related PDB Entry
9 entries where IM5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	2
Bond Count	39
Aromatic Bond Count	5

2D diagram of IM5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-amino-7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
Synonyms	DADMe-ImmG
Systematic Name (OpenEye OEToolkits)	2-azanyl-7-[[(3R,4R)-3-(hydroxymethyl)-4-oxidanyl-pyrrolidin-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
Formula	C₁₂ H₁₇ N₅ O₃
Molecular Weight	279.295
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C2NC(=Nc1c(cnc12)CN3CC(C(O)C3)CO)N
SMILES	CACTVS	3.370	NC1=Nc2c(CN3C[CH](O)[CH](CO)C3)c[nH]c2C(=O)N1
SMILES	OpenEye OEToolkits	1.7.6	c1c(c2c([nH]1)C(=O)NC(=N2)N)CN3CC(C(C3)O)CO
Canonical SMILES	CACTVS	3.370	NC1=Nc2c(CN3C[C@H](O)[C@@H](CO)C3)c[nH]c2C(=O)N1
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1c(c2c([nH]1)C(=O)NC(=N2)N)CN3C[C@@H]([C@H](C3)O)CO
InChI	InChI	1.03	InChI=1S/C12H17N5O3/c13-12-15-9-6(1-14-10(9)11(20)16-12)2-17-3-7(5-18)8(19)4-17/h1,7-8,14,18-19H,2-5H2,(H3,13,15,16,20)/t7-,8+/m1/s1
InChIKey	InChI	1.03	GSPTUGDLYPMLCQ-SFYZADRCSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL475750
PubChem	10171607, 135415984
ChEMBL	CHEMBL475750

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.